No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
GILD241213C91000
- 2.04
- +0.40+24.39%
15min DelayClose Dec 12 16:00 ET
2.04High0.96Low
0.96Open1.64Pre Close670 Volume171 Open Interest91.00Strike Price126.32KTurnover62.24%IV0.71%PremiumDec 13, 2024Expiry Date1.38Intrinsic Value100Multiplier1DDays to Expiry0.66Extrinsic Value100Contract SizeAmericanOptions Type0.6909Delta0.1214Gamma46.77Leverage Ratio-0.5685Theta0.0016Rho32.32Eff Leverage0.0164Vega
Intraday
- 5D
- Daily
News
Gilead Sciences: Berger to Succeed Merdad Parsey on Jan. 2
Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer
Express News | Gilead Sciences Appoints Dietmar Berger, Md, Phd, as Chief Medical Officer
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Is Gilead Sciences (GILD) Stock Undervalued Right Now?